Commentary: Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: a multi-omics analysis with experimental verification

Jihao Xue; Qijia Yin; Ming Wang; Yanling Li

doi:10.3389/fimmu.2024.1499286

Commentary: Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: a multi-omics analysis with experimental verification

Front Immunol. 2024 Dec 18:15:1499286. doi: 10.3389/fimmu.2024.1499286. eCollection 2024.

Authors

Jihao Xue^#¹, Qijia Yin^#^{2

3}, Ming Wang¹, Yanling Li⁴

Affiliations

¹ Department of Neurosurgery, the Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.
² Department of Urology or Nursing, Dazhou First People's Hospital, Dazhou, Sichuan, China.
³ College of Nursing, Chongqing Medical University, Chongqing, China.
⁴ Department of Rehabilitation or Nursing, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.

^# Contributed equally.

No abstract available

Keywords: cox regression; glioma; global test; nomogram; proportional hazards (PH) assumption.

Publication types

Comment

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Natural Science Foundation of Southwest Medical University, Grant (No. 2023QN008 and 2023QN103).